Investigating bleeding adverse events associated with BTK inhibitors in the Food and Drug Administration adverse event reporting system (FAERS)

CONCLUSION: Our findings indicate that bleeding AEs linked to BTK inhibitors in various conditions underscore the need for cautious clinical decision-making, particularly in nervous system disorders, injuries, poisoning, surgical complications, vascular disorders, and others.PMID:38568245 | DOI:10.1080/14740338.2024.2339448

Source: Expert Opinion on Drug Safety - April 3, 2024 Category: Drugs & Pharmacology Authors: Xianlin Li Nan Shang Qianci Yan Xiunan Yue Yang Liu Xiaojun Zheng Source Type: research